Robotic Versus Open Ventral Hernia Repair
Launched by LUCAS BEFFA · Jul 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different methods for repairing ventral hernias, which are bulges in the abdominal wall. One method is called open retromuscular repair, where the surgeon makes a larger cut to fix the hernia, and the other is robotic retromuscular repair, which uses advanced robotic tools to assist in the surgery. The goal is to see which method works better for patients.
To participate in this study, you need to be at least 18 years old and have a midline hernia that is between 7 and 15 centimeters wide. You should also have a body mass index (BMI) of 45 or lower. If you join the trial, you’ll be randomly assigned to one of the two surgery types, and your progress will be monitored over time. It's important to note that certain individuals, such as those under 18, pregnant women, or those with larger hernias, won't be eligible for this trial. The study is currently looking for participants, and everyone involved will receive care from skilled surgeons.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and older
- • 7 cm to 15 cm wide hernia midline defects
- • BMI less than or equal to 45
- • Patient deemed both an open and robotic candidate by operating surgeon
- Exclusion Criteria:
- • 17 years old or younger
- • prisoners
- • pregnant patients
- • Emergent patients
- • BMI greater than 45
- • Hernia defects less than 7 cm or greater than 15 cm in width
About Lucas Beffa
Lucas Beffa is a dedicated clinical trial sponsor recognized for its commitment to advancing medical research through innovative and ethical approaches. With a focus on enhancing patient care and outcomes, the organization collaborates with leading healthcare professionals and research institutions to design and implement rigorous clinical studies. Lucas Beffa prioritizes transparency, safety, and compliance, ensuring that all trials adhere to the highest regulatory standards while fostering a culture of scientific excellence. Through its efforts, Lucas Beffa aims to contribute significantly to the development of new therapies and treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Greenville, South Carolina, United States
Knoxville, Tennessee, United States
Gainesville, Florida, United States
Patients applied
Trial Officials
Lucas Beffa, MD
Principal Investigator
The Cleveland Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials